Table of Contents Author Guidelines Submit a Manuscript
International Journal of Polymer Science
Volume 2009, Article ID 617184, 16 pages
http://dx.doi.org/10.1155/2009/617184
Research Article

Genipin Cross-Linked Polymeric Alginate-Chitosan Microcapsules for Oral Delivery: In-Vitro Analysis

Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Physiology, Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, QC, Canada H3A 2B4

Received 24 September 2008; Revised 9 March 2009; Accepted 29 April 2009

Academic Editor: Miriam Rafailovich

Copyright © 2009 Hongmei Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. S. Chang, “Semipermeable microcapsules,” Science, vol. 146, no. 3643, pp. 524–525, 1964. View at Google Scholar
  2. T. M. S. Chang, “The role of artificial cells in cell and organ transplantation in regenerative medicine,” Panminerva Medica, vol. 47, no. 1, pp. 1–9, 2005. View at Google Scholar
  3. T. M. S. Chang, “Therapeutic applications of polymeric artificial cells,” Nature Reviews Drug Discovery, vol. 4, no. 3, pp. 221–235, 2005. View at Publisher · View at Google Scholar
  4. P. De Vos and P. Marchetti, “Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets,” Trends in Molecular Medicine, vol. 8, no. 8, pp. 363–366, 2002. View at Publisher · View at Google Scholar
  5. N. O. Dhoot and M. A. Wheatley, “Microencapsulated Liposomes in controlled drug delivery: strategies to modulate drug release and eliminate the burst effect,” Journal of Pharmaceutical Sciences, vol. 92, no. 3, pp. 679–689, 2003. View at Publisher · View at Google Scholar
  6. S. Freiberg and X. X. Zhu, “Polymer microspheres for controlled drug release,” International Journal of Pharmaceutics, vol. 282, no. 1-2, pp. 1–18, 2004. View at Publisher · View at Google Scholar
  7. G. Orive, R. M. Hernández, A. R. Gascón et al., “Cell encapsulation: promise and progress,” Nature Medicine, vol. 9, no. 1, pp. 104–107, 2003. View at Publisher · View at Google Scholar
  8. H. Tamber, P. Johansen, H. P. Merkle, and B. Gander, “Formulation aspects of biodegradable polymeric microspheres for antigen delivery,” Advanced Drug Delivery Reviews, vol. 57, no. 3, pp. 357–376, 2005. View at Publisher · View at Google Scholar
  9. N. K. Varde and D. W. Pack, “Microspheres for controlled release drug delivery,” Expert Opinion on Biological Therapy, vol. 4, no. 1, pp. 35–51, 2004. View at Publisher · View at Google Scholar
  10. C. K. Colton, “Engineering challenges in cell-encapsulation technology,” Trends in Biotechnology, vol. 14, no. 5, pp. 158–162, 1996. View at Publisher · View at Google Scholar
  11. S. R. Bhatia, S. F. Khattak, and S. C. Roberts, “Polyelectrolytes for cell encapsulation,” Current Opinion in Colloid & Interface Science, vol. 10, no. 1-2, pp. 45–51, 2005. View at Publisher · View at Google Scholar
  12. M. de Groot, T. A. Schuurs, and R. van Schilfgaarde, “Causes of limited survival of microencapsulated pancreatic islet grafts,” Journal of Surgical Research, vol. 121, no. 1, pp. 141–150, 2004. View at Publisher · View at Google Scholar
  13. A. Fery, F. Dubreuil, and H. Möhwald, “Mechanics of artificial microcapsules,” New Journal of Physics, vol. 6, pp. 1–13, 2004. View at Google Scholar
  14. E. Fournier, C. Passirani, C. N. Montero-Menei, and J. P. Benoit, “Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility,” Biomaterials, vol. 24, no. 19, pp. 3311–3331, 2003. View at Publisher · View at Google Scholar
  15. D. Hunkeler, A. Rehor, I. Ceausoglu et al., “Objectively assessing bioartificial organs,” Annals of the New York Academy of Sciences, vol. 944, pp. 456–471, 2001. View at Google Scholar
  16. A. Prokop, D. Hunkeler, A. C. Powers, R. R. Whitesell, and T. G. Wang, “Water soluble polymers for immunoisolation II: evaluation of multicomponent microencapsulation systems,” Advances in Polymer Science, vol. 136, pp. 53–73, 1998. View at Google Scholar
  17. H. Uludag, P. De Vos, and P. A. Tresco, “Technology of mammalian cell encapsulation,” Advanced Drug Delivery Reviews, vol. 42, no. 1-2, pp. 29–64, 2000. View at Publisher · View at Google Scholar
  18. J. Bloch, A. C. Bachoud-Lévi, N. Déglon et al., “Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study,” Human Gene Therapy, vol. 15, no. 10, pp. 968–975, 2004. View at Publisher · View at Google Scholar
  19. H. Zimmermann, D. Zimmermann, R. Reuss et al., “Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation,” Journal of Materials Science: Materials in Medicine, vol. 16, no. 6, pp. 491–501, 2005. View at Publisher · View at Google Scholar
  20. A. M. Rokstad, S. Holtan, B. Strand et al., “Microencapsulation of cells producing therapeutic proteins: optimizing cell growth and secretion,” Cell Transplantation, vol. 11, no. 4, pp. 313–324, 2002. View at Google Scholar
  21. B. R. S. Hsu, Y. S. Ho, S. H. Fu, Y. Y. Huang, S. C. Chiou, and H. S. Huang, “Membrane compactness affects the integrity and immunoprotection of alginate-poly-L-lysine-alginate microcapsules,” Transplantation Proceedings, vol. 27, no. 6, pp. 3227–3231, 1995. View at Google Scholar
  22. B. Thu, P. Bruheim, T. Espevik, O. Smidsrød, P. Soon-Shiong, and G. Skjåk-Bræk, “Alginate polycation microcapsules—II: some functional properties,” Biomaterials, vol. 17, no. 11, pp. 1069–1079, 1996. View at Publisher · View at Google Scholar
  23. F. Lim and A. M. Sun, “Microencapsulated islets as bioartifical endocrine pancreas,” Science, vol. 210, no. 4472, pp. 908–910, 1980. View at Google Scholar
  24. P. Soon-Shiong, R. E. Heintz, N. Merideth et al., “Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation,” The Lancet, vol. 343, no. 8903, pp. 950–951, 1994. View at Publisher · View at Google Scholar
  25. M. Zhou, D. Chen, Q. Yao, Z. Xia, C. Wang, and H. Zhu, “Microencapsulation of rat islets prolongs xenograft survival in diabetic mice,” Chinese Medical Journal, vol. 111, no. 5, pp. 394–397, 1998. View at Google Scholar
  26. M. Briššová, I. Lacík, A. C. Powers, A. V. Anilkumar, and T. Wang, “Control and measurement of permeability for design of microcapsule cell delivery system,” Journal of Biomedical Materials Research, vol. 39, no. 1, pp. 61–70, 1998. View at Publisher · View at Google Scholar
  27. J. M. Van Raamsdonk, R. M. Cornelius, J. L. Brash, and P. L. Chang, “Deterioration of polyamino acid-coated alginate microcapsules in vivo,” Journal of Biomaterials Science, Polymer Edition, vol. 13, no. 8, pp. 863–884, 2002. View at Publisher · View at Google Scholar
  28. X. Ma, I. Vacek, and A. Sun, “Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 22, no. 1, pp. 43–69, 1994. View at Google Scholar
  29. M. S. Wang, R. F. Childs, and P. L. Chang, “A novel method to enhance the stability of alginate-poly-L-lysine-alginate microcapsules,” Journal of Biomaterials Science, Polymer Edition, vol. 16, no. 1, pp. 91–113, 2005. View at Publisher · View at Google Scholar
  30. O. Gåserød, O. Smidsrød, and G. Skjåk-Bræk, “Microcapsules of alginate-chitosan - I. A quantitative study of the interaction between alginate and chitosan,” Biomaterials, vol. 19, no. 20, pp. 1815–1825, 1998. View at Publisher · View at Google Scholar
  31. R. H. Li, “Materials for immunoisolated cell transplantation,” Advanced Drug Delivery Reviews, vol. 33, no. 1-2, pp. 87–109, 1998. View at Publisher · View at Google Scholar
  32. M. C. P. Cruz, S. P. Ravagnani, F. M. S. Brogna et al., “Evaluation of the diffusion coefficient for controlled release of oxytetracycline from alginate/chitosan/poly(ethylene glycol) microbeads in simulated gastrointestinal environments,” Biotechnology and Applied Biochemistry, vol. 40, no. 3, pp. 243–253, 2004. View at Publisher · View at Google Scholar
  33. L. R. Moses, K. J. Dileep, and C. P. Sharma, “Beta cyclodextrin-insulin-encapsulated chitosan/alginate matrix: oral delivery system,” Journal of Applied Polymer Science, vol. 75, no. 9, pp. 1089–1096, 2000. View at Publisher · View at Google Scholar
  34. T. Metz, M. L. Jones, H. Chen et al., “A new method for targeted drug delivery using polymeric microcapsules: implications for treatment of Crohn's disease,” Cell Biochemistry and Biophysics, vol. 43, no. 1, pp. 77–85, 2005. View at Google Scholar
  35. P. R. Hari, T. Chandy, and C. P. Sharma, “Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin,” Journal of Microencapsulation, vol. 13, no. 3, pp. 319–329, 1996. View at Google Scholar
  36. S. Li, X.-T. Wang, X.-B. Zhang et al., “Studies on alginate-chitosan microcapsules and renal arterial embolization in rabbits,” Journal of Controlled Release, vol. 84, no. 3, pp. 87–98, 2002. View at Publisher · View at Google Scholar
  37. G. Coppi, V. Iannuccelli, E. Leo, M. T. Bernabei, and R. Cameroni, “Protein immobilization in crosslinked alginate microparticles,” Journal of Microencapsulation, vol. 19, no. 1, pp. 37–44, 2002. View at Publisher · View at Google Scholar
  38. S.-C. Chen, Y.-C. Wu, F.-L. Mi, Y.-H. Lin, L.-C. Yu, and H.-W. Sung, “A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery,” Journal of Controlled Release, vol. 96, no. 2, pp. 285–300, 2004. View at Publisher · View at Google Scholar
  39. D. K. Boadi and R. J. Neufeld, “Encapsulation of tannase for the hydrolysis of tea tannins,” Enzyme and Microbial Technology, vol. 28, no. 7-8, pp. 590–595, 2001. View at Publisher · View at Google Scholar
  40. K. W. Lee, J. J. Yoon, J. H. Lee et al., “Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan,” Transplantation Proceedings, vol. 36, no. 8, pp. 2464–2465, 2004. View at Publisher · View at Google Scholar
  41. T. Dastan and K. Turan, “In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 2, pp. 205–214, 2004. View at Google Scholar
  42. D. Quong and R. J. Neufeld, “DNA encapsulation within co-guanidine membrane coated alginate beads and protection from extracapsular nuclease,” Journal of Microencapsulation, vol. 16, no. 5, pp. 573–585, 1999. View at Publisher · View at Google Scholar
  43. C. Iyer and K. Kailasapathy, “Effect of co-encapsulation of probiotics with prebiotics on increasing the viability of encapsulated bacteria under in vitro acidic and bile salt conditions and in yogurt,” Journal of Food Science, vol. 70, no. 1, pp. M18–M23, 2005. View at Google Scholar
  44. W. Krasaekoopt, B. Bhandari, and H. Deeth, “The influence of coating materials on some properties of alginate beads and survivability of microencapsulated probiotic bacteria,” International Dairy Journal, vol. 14, no. 8, pp. 737–743, 2004. View at Publisher · View at Google Scholar
  45. J. S. Lee, D. S. Cha, and H. J. Park, “Survival of freeze-dried Lactobacillus bulgaricus KFRI 673 in chitosan-coated calcium alginate microparticles,” Journal of Agricultural and Food Chemistry, vol. 52, no. 24, pp. 7300–7305, 2004. View at Publisher · View at Google Scholar
  46. Y. Zhou, E. Martins, A. Groboillot, C. P. Champagne, and R. J. Neufeld, “Spectrophotometric quantification of lactic bacteria in alginate and control of cell release with chitosan coating,” Journal of Applied Microbiology, vol. 84, no. 3, pp. 342–348, 1998. View at Google Scholar
  47. D. W. Green, I. Leveque, D. Walsh et al., “Biomineralized polysaccharide capsules for encapsulation, organization, and delivery of human cell types and growth factors,” Advanced Functional Materials, vol. 15, no. 6, pp. 917–923, 2005. View at Publisher · View at Google Scholar
  48. T. Haque, H. Chen, W. Ouyang et al., “In vitro study of alginate-chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failure,” Biotechnology Letters, vol. 27, no. 5, pp. 317–322, 2005. View at Publisher · View at Google Scholar
  49. A. Zanina, A. Vilesov, and T. Budtova, “Shear-induced solvent release from gel particles: application to drug-delivery systems,” International Journal of Pharmaceutics, vol. 242, no. 1-2, pp. 137–146, 2002. View at Publisher · View at Google Scholar
  50. T. Chandy, D. L. Mooradian, and G. H. R. Rao, “Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation,” Artificial Organs, vol. 23, no. 10, pp. 894–903, 1999. View at Publisher · View at Google Scholar
  51. D. Maysinger, O. Berezovskaya, and S. Fedoroff, “The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS: (II) microencapsulated CSF-1 and LM-10 cells as delivery systems,” Experimental Neurology, vol. 141, no. 1, pp. 47–56, 1996. View at Publisher · View at Google Scholar
  52. G. Orive, A. Bartkowiak, S. Lisiecki et al., “Biocompatible oligochitosans as cationic modifiers of alginate/Ca microcapsules,” Journal of Biomedical Materials Research, Part B, vol. 74, no. 1, pp. 429–439, 2005. View at Publisher · View at Google Scholar
  53. W. E. Hennink and C. F. van Nostrum, “Novel crosslinking methods to design hydrogels,” Advanced Drug Delivery Reviews, vol. 54, no. 1, pp. 13–36, 2002. View at Publisher · View at Google Scholar
  54. L. Richert, F. Boulmedais, P. Lavalle et al., “Improvement of stability and cell adhesion properties of polyelectrolyte multilayer films by chemical cross-linking,” Biomacromolecules, vol. 5, no. 2, pp. 284–294, 2004. View at Publisher · View at Google Scholar
  55. S. G. Kumbar, A. R. Kulkarni, and T. M. Aminabhavi, “Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent,” Journal of Microencapsulation, vol. 19, no. 2, pp. 173–180, 2002. View at Publisher · View at Google Scholar
  56. H. Marchais, G. Cayzeele, J.-Y. Legendre, M. Skiba, and P. Arnaud, “Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release,” European Journal of Pharmaceutical Sciences, vol. 19, no. 2-3, pp. 129–132, 2003. View at Publisher · View at Google Scholar
  57. Y. Zhang, Y. Guan, and S. Zhou, “Single component chitosan hydrogel microcapsule from a layer-by-layer approach,” Biomacromolecules, vol. 6, no. 4, pp. 2365–2369, 2005. View at Publisher · View at Google Scholar
  58. G. M. Cruise, O. D. Hegre, F. V. Lamberti et al., “In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes,” Cell Transplantation, vol. 8, no. 3, pp. 293–306, 1999. View at Google Scholar
  59. R. Srivastava, J. Q. Brown, H. Zhu, and M. J. McShane, “Stabilization of glucose oxidase in alginate microspheres with photoreactive diazoresin nanofilm coatings,” Biotechnology and Bioengineering, vol. 91, no. 1, pp. 124–131, 2005. View at Publisher · View at Google Scholar
  60. I. Pastoriza-Santos, B. Schöler, and F. Caruso, “Core-shell colloids and hollow polyelectrolyte capsules based on diazoresins,” Advanced Funtional Materials, vol. 11, no. 2, pp. 122–128, 2001. View at Publisher · View at Google Scholar
  61. F. Shen, A. A. Li, R. M. Cornelius et al., “Biological properties of photocrosslinked alginate microcapsules,” Journal of Biomedical Materials Research, Part B, vol. 75, no. 2, pp. 425–434, 2005. View at Publisher · View at Google Scholar
  62. C. Nishi, N. Nakajima, and Y. Ikada, “In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification,” Journal of Biomedical Materials Research, vol. 29, no. 7, pp. 829–834, 1995. View at Publisher · View at Google Scholar
  63. H.-W. Sung, D.-M. Huang, W.-H. Chang, R.-N. Huang, and J.-C. Hsu, “Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: in vitro study,” Journal of Biomedical Materials Research, vol. 46, no. 4, pp. 520–530, 1999. View at Publisher · View at Google Scholar
  64. W. Friess, “Collagen—biomaterial for drug delivery,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 45, no. 2, pp. 113–136, 1998. View at Publisher · View at Google Scholar
  65. H.-W. Sung, I. L. Liang, C.-N. Chen, R.-N. Huang, and H.-F. Liang, “Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin),” Journal of Biomedical Materials Research, vol. 55, no. 4, pp. 538–546, 2001. View at Publisher · View at Google Scholar
  66. C. Djerassi, J. D. Gray, and F. A. Kincl, “Naturally occurring oxygen heterocyclics. 9. Isolation and characterization of genipin,” Journal of Organic Chemistry, vol. 25, no. 12, pp. 2174–2177, 1960. View at Google Scholar
  67. Y. Imanishi, N. Maeda, K. Otogawa et al., “Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats,” Journal of Hepatology, vol. 41, no. 2, pp. 242–250, 2004. View at Publisher · View at Google Scholar
  68. H.-J. Koo, Y. S. Song, H.-J. Kim et al., “Antiinflammatory effects of genipin, an active principle of gardenia,” European Journal of Pharmacology, vol. 495, no. 2-3, pp. 201–208, 2004. View at Publisher · View at Google Scholar
  69. I. Sakaida, M. Tsuchiya, K. Kawaguchi, T. Kimura, S. Terai, and K. Okita, “Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet,” Journal of Hepatology, vol. 38, no. 6, pp. 762–769, 2003. View at Publisher · View at Google Scholar
  70. J. Shoda, T. Miura, H. Utsunomiya et al., “Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver,” Hepatology, vol. 39, no. 1, pp. 167–178, 2004. View at Publisher · View at Google Scholar
  71. M. Yamazaki, K. Chiba, T. Mohri, and H. Hatanaka, “Cyclic GMP-dependent neurite outgrowth by genipin and nerve growth factor in PC12h cells,” European Journal of Pharmacology, vol. 488, no. 1–3, pp. 35–43, 2004. View at Publisher · View at Google Scholar
  72. Y.-S. Paik, C.-M. Lee, M.-H. Cho, and T.-R. Hahn, “Physical stability of the blue pigments formed from geniposide of gardenia fruits: effects of ph, temperature, and light,” Journal of Agricultural and Food Chemistry, vol. 49, no. 1, pp. 430–432, 2001. View at Publisher · View at Google Scholar
  73. F.-L. Mi, H.-W. Sung, and S.-S. Shyu, “Synthesis and characterization of a novel chitosan-based network prepared using naturally occurring crosslinker,” Journal of Polymer Science, Part A, vol. 38, no. 15, pp. 2804–2814, 2000. View at Publisher · View at Google Scholar
  74. F.-L. Mi, S.-S. Shyu, and C.-K. Peng, “Characterization of ring-opening polymerization of genipin and pH-dependent cross-linking reactions between chitosan and genipin,” Journal of Polymer Science, Part A, vol. 43, no. 10, pp. 1985–2000, 2005. View at Publisher · View at Google Scholar
  75. L. L. H. Huang, H.-W. Sung, C.-C. Tsai, and D.-M. Huang, “Biocompatibility study of a biological tissue fixed with a naturally occurring crosslinking reagent,” Journal of Biomedical Materials Research, vol. 42, no. 4, pp. 568–576, 1998. View at Publisher · View at Google Scholar
  76. B.-S. Liu, C.-H. Yao, Y.-S. Chen, and S.-H. Hsu, “In vitro evaluation of degradation and cytotoxicity of a novel composite as a bone substitute,” Journal of Biomedical Materials Research, Part A, vol. 67, no. 4, pp. 1163–1169, 2003. View at Google Scholar
  77. H.-W. Sung, R.-N. Huang, L. L. H. Huang, C.-C. Tsai, and C.-T. Chiu, “Feasibility study of a natural crosslinking reagent for biological tissue fixation,” Journal of Biomedical Materials Research, vol. 42, no. 4, pp. 560–567, 1998. View at Publisher · View at Google Scholar
  78. H.-W. Sung, R.-N. Huang, L. L. H. Huang, and C.-C. Tsai, “In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation,” Journal of Biomaterials Science, Polymer Edition, vol. 10, no. 1, pp. 63–78, 1999. View at Google Scholar
  79. M. F. Butler, Y.-F. Ng, and P. D. A. Pudney, “Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin,” Journal of Polymer Science, Part A, vol. 41, no. 24, pp. 3941–3953, 2003. View at Publisher · View at Google Scholar
  80. H.-W. Sung, W.-H. Chang, C.-Y. Ma, and M.-H. Lee, “Crosslinking of biological tissues using genipin and/or carbodiimide,” Journal of Biomedical Materials Research, vol. 64, no. 3, pp. 427–438, 2003. View at Google Scholar
  81. J. Jin, M. Song, and D. J. Hourston, “Novel chitosan-based films cross-linked by genipin with improved physical properties,” Biomacromolecules, vol. 5, no. 1, pp. 162–168, 2004. View at Publisher · View at Google Scholar
  82. F.-L. Mi, Y.-C. Tan, H.-C. Liang, R.-N. Huang, and H.-W. Sung, “In vitro evaluation of a chitosan membrane cross-linked with genipin,” Journal of Biomaterials Science, Polymer Edition, vol. 12, no. 8, pp. 835–850, 2001. View at Publisher · View at Google Scholar
  83. A. Bigi, G. Cojazzi, S. Panzavolta, N. Roveri, and K. Rubini, “Stabilization of gelatin films by crosslinking with genipin,” Biomaterials, vol. 23, no. 24, pp. 4827–4832, 2002. View at Publisher · View at Google Scholar
  84. H.-C. Liang, W.-H. Chang, K.-J. Lin, and H.-W. Sung, “Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies,” Journal of Biomedical Materials Research, Part A, vol. 65, no. 2, pp. 271–282, 2003. View at Google Scholar
  85. S. Fujikawa, S. Nakamura, and K. Koga, “Genipin, a new type of protein crosslinking reagent from gardenia fruits,” Agricultural and Biological Chemistry, pp. 869–870, 1988. View at Google Scholar
  86. W.-H. Chang, Y. Chang, Y.-C. Chen, and H.-W. Sung, “Hemoglobin polymerized with a naturally occurring crosslinking agent as a blood substitute: in vitro and in vivo studies,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 32, no. 2, pp. 243–262, 2004. View at Publisher · View at Google Scholar
  87. Y.-S. Chen, J.-Y. Chang, C.-Y. Cheng, F.-J. Tsai, C.-H. Yao, and B.-S. Liu, “An in vivo evaluation of a biodegradable genipin-cross-linked gelatin peripheral nerve guide conduit material,” Biomaterials, vol. 26, no. 18, pp. 3911–3918, 2005. View at Publisher · View at Google Scholar
  88. Y. Chang, H.-C. Liang, H.-J. Wei, C.-P. Chu, and H.-W. Sung, “Tissue regeneration patterns in acellular bovine pericardia implanted in a canine model as a vascular patch,” Journal of Biomedical Materials Research, Part A, vol. 69, no. 2, pp. 323–333, 2004. View at Google Scholar
  89. H.-C. Liang, Y. Chang, C.-K. Hsu, M.-H. Lee, and H.-W. Sung, “Effects of crosslinking degree of an acellular biological tissue on its tissue regeneration pattern,” Biomaterials, vol. 25, no. 17, pp. 3541–3552, 2004. View at Publisher · View at Google Scholar
  90. H. Chen, W. Ouyang, M. Jones et al., “Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy,” Cell Biochemistry and Biophysics, vol. 47, no. 1, pp. 159–167, 2007. View at Google Scholar
  91. C.-S. Ko and I.-M. Chu, “Immobilized cells biocatalyst for the production of S-acetylthio-2-methyl propionic acid,” Enzyme and Microbial Technology, vol. 35, no. 6-7, pp. 619–623, 2004. View at Publisher · View at Google Scholar
  92. H. Chen, W. Ouyang, B. Lawuyi, and S. Prakash, “Genipin cross-linked alginate-chitosan microcapsules: membrane characterization and optimization of cross-linking reaction,” Biomacromolecules, vol. 7, no. 7, pp. 2091–2098, 2006. View at Publisher · View at Google Scholar
  93. J. M. Van Raamsdonk and P. L. Chang, “Osmotic pressure test: a simple, quantitative method to assess the mechanical stability of alginate microcapsules,” Journal of Biomedical Materials Research, vol. 54, no. 2, pp. 264–271, 2001. View at Publisher · View at Google Scholar
  94. A. Martinsen, G. Skjåk-Bræk, and O. Smidsrød, “Alginate as immobilization material—I: correlation between chemical and physical properties of alginate gel beads,” Biotechnology and Bioengineering, vol. 33, no. 1, pp. 79–89, 1989. View at Google Scholar
  95. O. Smidsrød and G. Skjåk-Bræk, “Alginate as immobilization matrix for cells,” Trends in Biotechnology, vol. 8, no. 3, pp. 71–78, 1990. View at Google Scholar
  96. J. Dusseault, F. A. Leblond, R. Robitaille et al., “Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers,” Biomaterials, vol. 26, no. 13, pp. 1515–1522, 2005. View at Publisher · View at Google Scholar
  97. M. Darrabie, B. K. Freeman, W. F. Kendall Jr., H. A. Hobbs, and E. C. Opara, “Durability of sodium sulfate-treated polylysine-alginate microcapsules,” Journal of Biomedical Materials Research, vol. 54, no. 3, pp. 396–399, 2001. View at Publisher · View at Google Scholar
  98. C. J. D. Ross and P. L. Chang, “Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain,” Journal of Biomaterials Science, Polymer Edition, vol. 13, no. 8, pp. 953–962, 2002. View at Publisher · View at Google Scholar
  99. M. D. Darrabie, W. F. Kendall Jr., and E. C. Opara, “Characteristics of poly-L-ornithine-coated alginate microcapsules,” Biomaterials, vol. 26, no. 34, pp. 6846–6852, 2005. View at Publisher · View at Google Scholar
  100. M. Brissova, M. Petro, I. Lacík, A. C. Powers, and T. Wang, “Evaluation of microcapsule permeability via inverse size exclusion chromatography,” Analytical Biochemistry, vol. 242, no. 1, pp. 104–111, 1996. View at Publisher · View at Google Scholar
  101. W. W. Stewart and H. E. Swaisgood, “Characterization of calcium alginate pore diameter by size-exclusion chromatography using protein standards,” Enzyme and Microbial Technology, vol. 15, no. 11, pp. 922–927, 1993. View at Publisher · View at Google Scholar
  102. S. Rosiński, D. Lewińska, M. Wójcik, G. Orive, J. L. Pedraz, and A. Weryński, “Mass transfer characteristics of poly-lysine, poly-ornithine and poly-methylene-co-guanidine membrane coated alginate microcapsules,” Journal of Membrane Science, vol. 254, no. 1-2, pp. 249–257, 2005. View at Publisher · View at Google Scholar
  103. D. E. Awrey, M. Tse, G. Hortelano, and P. L. Chang, “Permeability of alginate microcapsules to secretory recombinant gene products,” Biotechnology and Bioengineering, vol. 52, no. 4, pp. 472–484, 1996. View at Publisher · View at Google Scholar
  104. M. Peirone, C. J. D. Ross, G. Hortelano, J. L. Brash, and P. L. Chang, “Encapsulation of various recombinant mammalian cell types in different alginate microcapsules,” Journal of Biomedical Materials Research, vol. 42, no. 4, pp. 587–596, 1998. View at Publisher · View at Google Scholar
  105. N. Okada, H. Miyamoto, T. Yoshioka et al., “Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA) membrane following allogeneic transplantation,” Biochemical and Biophysical Research Communications, vol. 230, no. 3, pp. 524–527, 1997. View at Publisher · View at Google Scholar
  106. M. F. A. Goosen, G. A. King, C. A. McKnight, and N. Marcotte, “Animal cell culture engineering using alginate polycation microcapsules of controlled membrane molecular weight cut-off,” Journal of Membrane Science, vol. 41, pp. 323–343, 1989. View at Publisher · View at Google Scholar
  107. M. Goldberg and I. Gomez-Orellana, “Challenges for the oral delivery of macromolecules,” Nature Reviews Drug Discovery, vol. 2, no. 4, pp. 289–295, 2003. View at Google Scholar
  108. S. Salminen and M. Gueimonde, “Human studies on probiotics: what is scientifically proven,” Journal of Food Science, vol. 69, no. 5, pp. M137–M140, 2004. View at Google Scholar
  109. V. Chandramouli, K. Kailasapathy, P. Peiris, and M. Jones, “An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions,” Journal of Microbiological Methods, vol. 56, no. 1, pp. 27–35, 2004. View at Publisher · View at Google Scholar
  110. J. Kovacs-Nolan and Y. Mine, “Microencapsulation for the gastric passage and controlled intestinal release of immunoglobulin Y,” Journal of Immunological Methods, vol. 296, no. 1-2, pp. 199–209, 2005. View at Publisher · View at Google Scholar
  111. A. Lamprecht, H. Yamamoto, H. Takeuchi, and Y. Kawashima, “Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 59, no. 2, pp. 367–371, 2005. View at Publisher · View at Google Scholar
  112. Y.-H. Lin, H.-F. Liang, C.-K. Chung, M.-C. Chen, and H.-W. Sung, “Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs,” Biomaterials, vol. 26, no. 14, pp. 2105–2113, 2005. View at Publisher · View at Google Scholar
  113. V. Pillay and R. Fassihi, “In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract—II: physicochemical characterization of calcium-alginate, calcium-pectinate and calcium-alginate-pectinate pellets,” Journal of Controlled Release, vol. 59, no. 2, pp. 243–256, 1999. View at Publisher · View at Google Scholar
  114. I. El-Gibaly, “Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres,” International Journal of Pharmaceutics, vol. 249, no. 1-2, pp. 7–21, 2002. View at Publisher · View at Google Scholar
  115. J. Brown, N. Madit, E. T. Cole, I. R. Wilding, and D. Cadé, “The effect of cross-linking on the in vivo disintegration of hard gelatin capsules,” Pharmaceutical Research, vol. 15, no. 7, pp. 1026–1030, 1998. View at Publisher · View at Google Scholar
  116. K. G. H. Desai and H. J. Park, “Encapsulation of vitamin C in tripolyphosphate cross-linked chitosan microspheres by spray drying,” Journal of Microencapsulation, vol. 22, no. 2, pp. 179–192, 2005. View at Publisher · View at Google Scholar
  117. M. C. Meyer, A. B. Straughn, R. M. Mhatre et al., “The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules,” Pharmaceutical Research, vol. 17, no. 8, pp. 962–966, 2000. View at Publisher · View at Google Scholar
  118. M.-K. Park, S. Deng, and R. C. Advincula, “Sustained release control via photo-cross-linking of polyelectrolyte layer-by-layer hollow capsules,” Langmuir, vol. 21, no. 12, pp. 5272–5277, 2005. View at Publisher · View at Google Scholar
  119. E. Taqieddin and M. Amiji, “Enzyme immobilization in novel alginate-chitosan core-shell microcapsules,” Biomaterials, vol. 25, no. 10, pp. 1937–1945, 2004. View at Publisher · View at Google Scholar
  120. H. Chen, W. Ouyang, M. Jones, T. Haque, B. Lawuyi, and S. Prakash, “In-vitro analysis of APA microcapsules for oral delivery of live bacterial cells,” Journal of Microencapsulation, vol. 22, no. 5, pp. 539–547, 2005. View at Publisher · View at Google Scholar